These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11345055)

  • 21. New options for prevention and control of influenza.
    Patriarca PA
    JAMA; 1999 Jul; 282(1):75-7. PubMed ID: 10404915
    [No Abstract]   [Full Text] [Related]  

  • 22. [New preparations against influenza].
    Westergren T
    Tidsskr Nor Laegeforen; 2001 Feb; 121(4):466-7. PubMed ID: 11255865
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antiviral agents for influenza].
    Mitamura K
    Nihon Rinsho; 2003 Feb; 61 Suppl 2():798-803. PubMed ID: 12722319
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of zanamivir treatment on the early immune response to influenza vaccination.
    Cox RJ; Mykkeltvedt E; Sjursen H; Haaheim LR
    Vaccine; 2001 Sep; 19(32):4743-9. PubMed ID: 11535325
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in in vitro susceptibility of influenza A H3N2 viruses to a neuraminidase inhibitor drug during evolution in the human host.
    Thompson CI; Barclay WS; Zambon MC
    J Antimicrob Chemother; 2004 May; 53(5):759-65. PubMed ID: 15028666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities.
    Li J; Zheng M; Tang W; He PL; Zhu W; Li T; Zuo JP; Liu H; Jiang H
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5009-13. PubMed ID: 16876409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new antiviral agent for influenza--is there a clinical niche?
    Couch RB
    N Engl J Med; 1997 Sep; 337(13):927-8. PubMed ID: 9302309
    [No Abstract]   [Full Text] [Related]  

  • 28. Synthesis and influenza virus sialidase inhibitory activity of analogues of 4-Guanidino-Neu5Ac2en (Zanamivir) modified in the glycerol side-chain.
    Andrews DM; Cherry PC; Humber DC; Jones PS; Keeling SP; Martin PF; Shaw CD; Swanson S
    Eur J Med Chem; 1999; 34(7-8):563-74. PubMed ID: 11278042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Flu and antiviral agents....].
    Vallée JP
    Presse Med; 2000 Jan; 29(2):84-5. PubMed ID: 10682036
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neuraminidase inhibitor permitted. The first pill against influenza].
    MMW Fortschr Med; 2002 Oct; 144(41):56. PubMed ID: 12474367
    [No Abstract]   [Full Text] [Related]  

  • 31. Elderly people's technique in using dry powder inhalers. Zanamivir and unreason seem to go together.
    Hall GH
    BMJ; 2001 Jul; 323(7303):50. PubMed ID: 11464829
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants.
    Gubareva LV; Webster RG; Hayden FG
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3403-8. PubMed ID: 11709315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A revolutionary change in the diagnosis and treatment of influenza].
    Sugaya N
    Uirusu; 2002 Jun; 52(1):47-53. PubMed ID: 12227179
    [No Abstract]   [Full Text] [Related]  

  • 34. The anti-influenza virus agent 4-GU-DANA (zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA.
    Greengard O; Poltoratskaia N; Leikina E; Zimmerberg J; Moscona A
    J Virol; 2000 Dec; 74(23):11108-14. PubMed ID: 11070006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses.
    Hurt AC; Barr IG; Komadina N; Hampson AW
    Virus Res; 2004 Jul; 103(1-2):79-83. PubMed ID: 15163493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors.
    Cheam AL; Barr IG; Hampson AW; Mosse J; Hurt AC
    Antiviral Res; 2004 Sep; 63(3):177-81. PubMed ID: 15451185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating influenza with zanamivir.
    Read RC
    Lancet; 1998 Dec; 352(9144):1872-3. PubMed ID: 9863779
    [No Abstract]   [Full Text] [Related]  

  • 38. Virology. The origin and control of pandemic influenza.
    Laver G; Garman E
    Science; 2001 Sep; 293(5536):1776-7. PubMed ID: 11546857
    [No Abstract]   [Full Text] [Related]  

  • 39. Neuraminidase inhibitors and relief of influenza symptoms.
    Lemon M; Meade F
    S D J Med; 2000 Mar; 53(3):99-100. PubMed ID: 10745653
    [No Abstract]   [Full Text] [Related]  

  • 40. [Neuraminidase inhibitor].
    Kaji M
    Nihon Rinsho; 2000 Nov; 58(11):2293-8. PubMed ID: 11225320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.